An Abrupt Hepatitis B Seroconversion

Does hepatitis B seroconversion affect survival outcome in patients with hepatitis B related hepatocellular carcinoma?

BACKGROUND Little is known about whether hepatitis B surface antigen (HBsAg) seroconversion (SC) contributes to any survival benefits for patients with hepatocellular carcinoma (HCC). METHODS All patients with hepatitis B-related HCC and HBsAg seroclearance between 1989 and 2013 were identified. Case- and control-groups were matched according to their stage of disease and mode of treatment. B...

Dilemma of HBsAg seroconversion in chronic hepatitis B infection

Patients with chronic hepatitis B infection should be followed up to identify possible changes in disease status, such as HBsAg seronversion. There are little data on the outcome of such cases, and the response rate to HBV vaccine has not been discussed extensively.

Hepatitis B surface antigen seroconversion in HBeAg negative chronic hepatitis B patient during entecavir treatment.

Chronic hepatitis B (CHB) infection is still a huge public health problem despite the development of new drugs for its treatment, and complications of end-stage liver disease due to this infection results in one million deaths worldwide annually (1). The ideal end-point of therapy is hepatitis B surface antigen (HBsAg) loss with or without HBs seroconversion. However, it is frequently not achie...

dilemma of hbsag seroconversion in chronic hepatitis b infection

seroconversion rates after hepatitis-b vaccination in children

background: hepatitis- b infection is one of the infectious diseases that transmits via blood transfiosion, blood product, injection, mother to fetus and sexual contact. protective anti hepatitis-b titer are observed in more than 90% of healthy children. the aim of this study was to evaluate seroconversion rates in children who received routine vaccination program. methods: a cross sectional st...